Cargando…
Targeted Optical Imaging of the Glucagonlike Peptide 1 Receptor Using Exendin-4-IRDye 800CW
The treatment of choice for insulinomas and focal lesions in congenital hyperinsulinism (CHI) is surgery. However, intraoperative detection can be challenging. This challenge could be overcome with intraoperative fluorescence imaging, which provides real-time lesion detection with a high spatial res...
Autores principales: | Boss, Marti, Bos, Desiree, Frielink, Cathelijne, Sandker, Gerwin, Ekim, Selen, Marciniak, Camille, Pattou, Francois, van Dam, Go, van Lith, Sanne, Brom, Maarten, Gotthardt, Martin, Buitinga, Mijke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Society of Nuclear Medicine
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7383075/ https://www.ncbi.nlm.nih.gov/pubmed/31924726 http://dx.doi.org/10.2967/jnumed.119.234542 |
Ejemplares similares
-
Receptor-Targeted Photodynamic Therapy of Glucagon-Like Peptide 1 Receptor–Positive Lesions
por: Boss, Marti, et al.
Publicado: (2020) -
Safety of panitumumab-IRDye800CW and cetuximab-IRDye800CW for fluorescence-guided surgical navigation in head and neck cancers
por: Gao, Rebecca W., et al.
Publicado: (2018) -
Exendin‐4 analogs in insulinoma theranostics
por: Jansen, Tom.J.P., et al.
Publicado: (2019) -
Near-Infrared Fluorescence Imaging of EGFR-Overexpressing Tumors in the Mouse Xenograft Model Using scFv-IRDye800CW and Cetuximab-IRDye800CW
por: Amini, Abolfazl, et al.
Publicado: (2022) -
Non-invasive in vivo determination of viable islet graft volume by (111)In-exendin-3
por: Eter, Wael A., et al.
Publicado: (2017)